Closing Bell: Hls Therapeutics Inc down on Tuesday (HLS)

Hls Therapeutics Inc opened trading today at $3.26 and closed at $3.26. Intraday prices ranged from $3.26 to $3.26.

Shares eased -2.69 percent from the previous day's close of $3.35.

During the day across North America, the TSX Composite closed 0.20% at 22824.67, the S&P 500 closed 0.08% at 5463.54, the Dow Jones Industrial Average closed -0.12% at 40539.93 and the Nasdaq Composite closed 0.07% at 17370.20.

Hls Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker HLS.

A total of 100 shares was traded during the session, with total trades of 1, with an average volume of 97,484 over the last 5 days.

The TSX overall saw 2,584 price advancers against 2,644 declines and 86 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $6.30 (August 01,2023) and low as $3.07 (July 24,2024). Moreover, in the last 52 weeks, Hls Therapeutics Inc's shares have shrunken -47.25%, while they have dipped -17.47% since the start of 2024.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $106.58 million on a float of 31,815 shares outstanding. Its annual EPS is $-0.86.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Currently, Hls Therapeutics Inc's consensus rating is "Moderate Buy" based on 5 analysts according to Zacks. Currently, there are 3 buy ratings and 2 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..